Navigation Links
Can Cholesterol Drugs Kill Prostate Cancer Cells? - Dr. David Samadi
Date:4/26/2016

According to world renowned prostate cancer surgeon, Dr. David B. Samadi of Lenox Hill Hospital, “one of the standard treatments for prostate cancer, especially more advanced cases of the disease can include chemotherapy.” Problematically, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness to fight the prostate cancer. Trying to combat these resistant cancer cells, researchers have been able to use a compound initially developed as a cholesterol-fighting molecule to stop and kill cancerous prostate cells.

Researchers at the University of Missouri focused on reducing the production of cholesterol in cancer cells, which could kill cancer cells and reduce the need for toxic chemotherapy. Although patients initially respond to chemotherapy treatments, prostate cancer cells can develop resistance and cause the spread of the prostate cancer. Finding a way to use the cholesterol pathway to target tumor cells and tumor growth, better therapeutic targets can lead to better treatment of prostate cancer.

Researchers used a compound developed by Roche Pharmaceuticals for the treatment of high cholesterol on human prostate cancer cells, and found that the compound was effective in reducing human prostate cancer cell growth. Later studies have found that the compound kills these cancer cells as well. According to Dr. Samadi, “This study highlights the potential of an old cholesterol drug, when in conjunction within standard chemo drugs to fight prostate cancer.”

Chemotherapy involves taking certain drugs that work to kill the cancer cells. Chemo usually lasts for a couple of weeks and may involve having more than one round. This type of treatment is usually used when the cancer has spread beyond the prostate and to other areas of the body.

Some symptoms and side-effects of chemotherapy include:

  • Appetite loss
  • Changes in sense of taste/smell
  • Constipation
  • Diarrhea
  • Dry mouth
  • Lactose Intolerance
  • Nausea
  • Sore Mouth
  • Vomiting
  • Sore throat
  • Trouble swallowing
  • Weight gain
  • Weight loss

Dr. Samadi also notes that, “Several recent papers have suggested that statins, medications for cholesterol such as Lipitor and Zocor, may impact prostate cancer development and progression. Considering that these drugs have revolutionized the prevention of heart disease, could these drugs truly be killing two birds with one stone? We would like to think so, and although this is exciting news, we need to be careful in how we interpret these findings.” It remains too early to recommend starting men on statins or other cholesterol fighting drugs to prevent prostate cancer.

Patients who are newly diagnosed with prostate cancer can contact world renowned prostate cancer surgeon and urologic oncologist, Dr. David Samadi, for a phone consultation. Call 212.365.5000 to set up your consultation with Dr. Samadi.

Read the full story at http://www.prweb.com/releases/David_Samadi/Prostate_Health/prweb13365652.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Wright Now Fitness: How Exercise Can Improve Cholesterol Levels
2. Cholesterol Metabolism Linked to HIV Progression
3. NutritionInstructorMD Presents New Ways on How to Manage Cholesterol
4. Myths About Cholesterol-Lowering Statins - February 2015 Harvard Heart Letter
5. Bel Marra Health Reports on Cholesterol-Lowering Power of Avocados
6. Lipitor Lawsuit Filings Alleging The Development of Type 2 Diabetes After Using The Cholesterol Lowering Medication Continue To Rise, Wright & Schulte LLC Reports
7. Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts
8. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Suggesting a Possible Alternative to Cholesterol-Lowering Statins
9. Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk
10. Experimental Cholesterol-Lowering Drug Effective, Study Reports
11. Diet Doc Announces Updated Medical Weight Loss Programs that Teach Patients How to Lower Bad Cholesterol Levels with Safe, Healthy and Fast Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... CEFEX, the Centre ... to the standards representing best practices in the retirement plan industry. The independent ... and helps to verify that NFP’s retirement division focuses on putting clients’ interests ...
(Date:8/23/2017)... Mesa, Arizona (PRWEB) , ... August 23, 2017 ... ... is in the top 20% of hospitals nationally that earned the designation of ... annual list. An overall rating of high performing indicates a hospital was significantly better ...
(Date:8/23/2017)... ... August 23, 2017 , ... TSC ... Awards® - for Risk Management Solution Innovations and Security Solution for Government Innovations. ... released in 2017 and its DHS SAFETY Act-designated enterprise security assessment approach. , ...
(Date:8/22/2017)... ... August 22, 2017 , ... The ... health is as simple as eating healthy foods. But this well-known piece of ... making insulin, or breaking apart carbohydrates—depends not only on properties of the food ...
(Date:8/22/2017)... ... ... Nurses at Apple Rehab Watch Hill , a nursing and rehabilitation ... in Closed Pulse Irrigation™ (CPI) for wound care. This qualifies Apple ... Medicare and Medicaid Services, to have a CPI machine that will provide better quality ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 Fenita ... Who as a Pinnacle Lifetime Professional in the ... Account Manager at Turing Pharmaceuticals, AG. Her skills ... and relationship building.                ... than 25 years of experience as a highly ...
(Date:8/2/2017)... , Aug. 2, 2017  Life Flight Network and PeaceHealth ... agreement improves patient care and operational efficiency for patients at ... , Cottage Grove , and ... transportation. PeaceHealth and Life Flight Network work collaboratively to move ... transport, or when a time sensitive emergency exists. ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: